Section 3.5.4: Glucocorticoid therapy (from DOI: 10.1080/22221751.2020.1735265)
Jump to navigation
Jump to search
| Sections in this Publication | |
|---|---|
| Named Entities in this Section |
From publication: "Diagnosis and clinical management of severe acute respiratory syndrome Coronavirus 2 (SARS-CoV-2) infection: an operational recommendation of Peking Union Medical College Hospital (V2.0)" in the journal Emerg Microbes Infect (2020)
https://doi.org/10.1080/22221751.2020.1735265
Section 3.5.4: Glucocorticoid therapy
Severe patients could receive glucocorticoid at early stage, e.g. intravenous methylprednisolone 40-80 mg, once daily for 5 days, and the course of treatment can be prolonged according to the clinical condition and radiological manifestations.
Go to next section in publication
